Linike Medical Group (LNMG) Financial Statements
Linike Medical Group Financial Overview
Linike Medical Group's market cap is currently $5.01M. The company's EPS TTM is $0.00; its P/E ratio is 5.35; Linike Medical Group has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Oct 25 | Oct 24 | Oct 23 | Oct 22 | Oct 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 10.68M | $ 13.05M | $ 8.95M | $ 0.00 | $ 0.00 |
| Gross Profit | $ 10.54M | $ 12.99M | $ 8.89M | $ 0.00 | $ 0.00 |
| Operating Income | $ 3.09M | $ -244.88K | $ 991.04K | $ -65.98K | $ -29.86K |
| EBITDA | $ 3.22M | $ -189.76K | $ 1.06M | $ -65.98K | $ -29.86K |
| Net Income | $ 3.09M | $ -244.88K | $ 991.04K | $ -65.98K | $ -29.86K |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 491.82K | $ 687.91K | $ 789.41K | $ 1.41K | $ 1.14K |
| Total Assets | $ 57.67M | $ 55.65M | $ 54.70M | $ 1.41K | $ 3.75K |
| Total Debt | $ 17.40M | $ 18.18M | $ 17.08M | $ 63.30K | $ 44.16K |
| Net Debt | $ 16.91M | $ 17.50M | $ 16.29M | $ 61.89K | $ 43.02K |
| Total Liabilities | $ 19.68M | $ 20.75M | $ 19.56M | $ 76.68K | $ 51.88K |
| Stockholders' Equity | $ 37.99M | $ 34.90M | $ 35.14M | $ -75.27K | $ -48.13K |
| Cash Flow | |||||
| Free Cash Flow | $ -262.71K | $ -994.65K | $ -2.32M | $ -19.15K | $ -22.01K |
| Operating Cash Flow | $ -15.31K | $ -766.55K | $ -2.26M | $ -19.15K | $ -22.01K |
| Investing Cash Flow | $ -247.40K | $ -228.10K | $ -58.78K | $ 0.00 | $ 0.00 |
| Financing Cash Flow | $ 66.62K | $ 620.04K | $ 2.04M | $ 19.15K | $ 23.43K |
Currency in USD
